New WHO-backed research outlines strategies to prevent postpartum hemorrhage deaths
A three-part series published in The Lancet proposes a comprehensive set of interventions to prevent and treat postpartum hemorrhage, the leading cause of maternal death responsible for 43,000 deaths annually. The research, co-authored by WHO physicians, draws on a large trial across Nigeria, Kenya, Tanzania, and South Africa involving more than 200,000 women. Authors say adopting existing tools and protocols could reduce postpartum hemorrhage deaths by more than 95%.
Postpartum hemorrhage affects approximately 27 million women each year and can kill within 10 to 20 minutes if untreated, making it the world's leading cause of maternal death. A new three-part Lancet series, co-authored by WHO physician Dr. Olufemi Oladapo and colleagues, synthesizes available evidence and proposes a bundle of interventions including calibrated blood-collection drapes for early detection, uterine massage, medication, and IV fluids administered simultaneously. A large clinical trial spanning four African countries and more than 200,000 women found this coordinated approach produced a significant decrease in severe bleeding. The series highlights a stark global disparity: while postpartum hemorrhage rates are similar across wealthy and low-income countries, mortality can be more than 200 times higher in under-resourced settings such as Afghanistan, Vietnam, and Nigeria compared to high-income countries like the United States. Key barriers in lower-resource settings include the need to refrigerate the frontline drug oxytocin and gaps in team-based training. Researchers argue the economic case is also compelling, estimating that investing even 5% of current hemorrhage-related costs in prevention would save both lives and money. Experts not involved in the research called the series a significant call to action and expressed optimism that eliminating postpartum hemorrhage as the leading cause of maternal death is achievable this decade.
What's missing
The series focuses on prevention and treatment protocols but does not detail specific funding mechanisms or implementation timelines for scaling recommendations in low-resource settings.
What different sources said
- NPR NewsLeft
What would it take to stop women from bleeding to death after childbirth?
Related
Tick Populations Surge in Urban Areas Across Northeast
Tick populations are expanding into urban green spaces and reaching record early-season activity levels across the northeastern United States and Canada, alarming public health officials. Submissions to Pennsylvania's tick research lab rose 50 percent in March and April, Washington D.C. saw bites a month earlier than usual, and a Canadian researcher collected 13 ticks in a single hour. The spread raises concerns not only about Lyme disease but also about alpha-gal syndrome, an emerging red-meat allergy triggered by lone star tick bites that is reshaping daily life and local economies in heavily affected areas.
Study suggests eating 5 fruits and vegetables daily may not provide enough heart-protective compounds
A new study published in the journal Food & Function found that fewer than 25% of people who met standard fruit and vegetable dietary guidelines consumed enough flavanols — plant compounds linked to cardiovascular benefits — to reach the 500mg daily threshold associated with a 27% reduction in cardiovascular disease mortality. Researchers from the University of Reading, Harvard Medical School, UC Davis, and Mars, Inc. analyzed dietary and biomarker data from more than 30,000 adults in the US and UK. The findings suggest that the specific types of fruits and vegetables consumed matter as much as the total quantity, pointing to a potential gap in current dietary guidance.
Stanford researchers develop treatment that restores cartilage and reverses arthritis in mice and human tissue
Stanford Medicine researchers have restored lost knee cartilage in aging mice and prevented post-injury arthritis by blocking a protein called 15-PGDH, with human tissue samples from knee replacement patients also showing cartilage regrowth after one week of treatment. The study, published in the journal Science, identifies 15-PGDH as a "gerozyme" — a protein that increases with age and suppresses tissue regeneration — and found that inhibiting it shifts cartilage cells toward a younger, healthier state without requiring stem cells. The findings raise the possibility of injectable or oral treatments that could slow or reverse osteoarthritis, a condition affecting roughly one in five U.S. adults with no currently approved disease-modifying therapies.